For the year ending 2025-12-31, PHIO has $21,487K in assets. $1,340K in debts. $21,031K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 21,031 | |||
| Prepaid expenses and other current assets | 445 | |||
| Total current assets | 21,476 | |||
| Property, plant and equipment, gross | 239 | |||
| Less accumulated depreciation and amortization | 228 | |||
| Property and equipment, net | 11 | |||
| Total assets | 21,487 | |||
| Accounts payable | 435 | |||
| Accrued expenses | 905 | |||
| Total liabilities | 1,340 | |||
| Common stock, 0.0001 par value, 100,000,000 shares authorized 11,617,250 and 1,733,717 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 1 | |||
| Additional paid-in capital | 175,200 | |||
| Accumulated deficit | -155,054 | |||
| Total stockholders' equity | 20,147 | |||
| Total liabilities and stockholders' equity | 21,487 | |||
Phio Pharmaceuticals Corp. (PHIO)
Phio Pharmaceuticals Corp. (PHIO)